Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation

Circulation

Volumn 97, Issue 11, 1998, Pages 1046-1052

  Rupprecht, Hans Jürgen ^a   Darius, Harald ^a   Borkowski, Ulrike ^a   Voigtländer, Thomas ^a   Nowak, Bernd ^a   Genth, Sabine ^a   Meyer, Jürgen ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Aspirin; Platelet aggregation inhibitors; Stents

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; COLLAGEN; FIBRINOGEN; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; PADGEM PROTEIN; TICLOPIDINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STENT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 0032562266     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.11.1046     Document Type: Article

References (29)

1. Schömig A, Neumann FJ, Kastrati A, Shühlen H, Blasini R, Hadamitzky M, Walter H, Zitzmann-Roth EM, Richardt G, Alt E, Schmitt C, Ulm K. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med. 1996;334:1084-1089.
2. Morice MC, Zemour G, Benviste E, Biron Y, Bourdonnec C, Faivre R, Fajadet J, Gaspard P, Glatt B, Joly P, Labrunie P, Lienhart Y, Marco J, Petiteau PY, Royer T, Valeix B. Intracoronary stenting without coumadin: one month results of a French Multicenter Study. Cathet Cardiovasc Diagn. 1995;35:1-7.
3. Neumann FJ, Walter H, Richardr G, Schmitt C, Schömig A. Coronary Palmaz-Schatz stent implantation in acute myocardial infarction. Heart. 1996;75:121-126.
4. Saito S, Hosokawa G, Kim K, Tanaka S, Miyake S. Primary stent implantation without Coumadin in acute myocardial infarction. J Am Coll Cardiol. 1996;28:74-81.
5. Karrillon GJ, Morice MC, Benveniste E, Bunouf P, Aubry P, Cattan S, Chevalier B, Commeau P, Cribier A, Eiferman C, Grollier G, Gueŕin Y, Henry M, Lefevre T, Livark B, Louvard Y, Marco J, Makowski S, Monassier JP, Perens JM, Rioux P, Spaulding C, Zemour G. Intracoronary stent implatation without ultrsound guidance and with replacement of conventional anticoagulation by antiplatelet therapy: 30-day clinical outcome of the frenchy multicenter registry. Circulation. 1996;94:1519-1527.
6. Eeckhout E, Kappenberger L, Goy JJ. Stents for intracoronary placement: current status and future directions. J Am Coll Cardiol. 1996;27:757-765.
7. Mak KH, Belli G, Ellis SG, Moliterno DJ. Subacute stent thrombosis: evolving issues and current concepts. J Am Coll Cardiol. 1996;27:494-503.
8. Fisch A, Tobusch K, Veit K, Meyer J, Darius H. Prostacyclin receptor desensitization is a reversible phenomenon in human platelets. Circulation. 1997;96:756-760.
9. Sigwart U, Puel J, Mircovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplstystents to prevent occlusion and restenosis after transluminal angioplsty N Engl J Med. 1987;316:701-706.
10. Bittle JA. Coronary stent occlusion: thrombosis horribilis. J Am Coll Cardial. 1996;28:368-370.
11. Hasdal D, Garratt KN, Holmes DR Jr, Berger PB, Schwartz RS, Belll MR. Coronary anfioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis. J Am Coll Cardiol. 1996;28:361-367.
12. Fernandez-Avilés F, Alonso JJ, Duran JM, Gimeno F, Munoz JC, de la Fuente L, San Roman JA. Subacute occlusion, bleeding complications, hospital stay and restenosis after Palmaz-Schatz coronary stenting under a new antithrombotic regimen. J Am Coll Cardiol. 1996;27:22-29.
13. Jeong MH, Owen WG, Staab ME, Srivatsa SS, Sangiorgi G, Stewart M, Holmes DR Jr, Schwartz RS. Porcine model of stent thrombosis: platelets are the primary component of acute stent closure. Cathet Cardiovasc Diagn. 1996;38:38-43.
14. Hardhammar PA, van Beusckom HMM, Emaanuelsson HU, Hofma SH, Albersson PA, Verdouw PD, Boersma E, Seruys PW, van der Giessen WJ. Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation. 1996;93:423-430.
15. Barragan P, Sainsous J, Silvestri M, Bouvier JL, Comet B, Sime ́oni JB, Charmasson C, Bremondy M. Ticlopidine and subcutaneous heparin as an alternative regiment followinf coronary stenting. Cathet Cardiovasc Diagn. 1994;32:133-138.
16. Buchwald AB, Sandrock D, Unterberg C, Ebbecke M, Nebendahl K, Lüders S, Munz DL, Wiegand V. Platelet and deposition on coronary stents in minipigs: effect of hirudin versus heparin. J Am Coll Cardiol. 1993;21:249-254.
17. Hafner G, Swars H, Erbel R, Ehrenthal W, Rupprecht HJ, Lotz J, Meyer J, Prellwitz W. Monitoring prothrombin fragment 1+2 during initiation of oral anticoagulant therapy after intracoronary stenting. Ann Hematol. 1992;65:83-87.
18. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martinin G, Gaglione A, Goldberg SL, Tobis JM. Intracoronary stenting without anticoagultion accomplished with intravascular ultrasound guidance. Circulation. 1995;91:1676-1688.
19. Serruys PW, Emanuelsson H, van der Giessen W, Lunn AC, Kiemeney F, Macaya C, Rutsch W, Heyndrickx G, Suryapranata H, Legrand V, Goy JJ, Materne P, Bonnier H, Morice MC, Fajadet J, Belardi J, Colombo A, Garcia E, Ruygrok P, de Jaegere P, Morel MA, on behalf of the Benestent-II Study Group. Heparin-coated Palmaz-Schatz stents in human coronary arteries: early outcome of the Benestent-II Pilot Study. Circulation. 1996;93:412-422.
20. Haude M, Hafner G, Jablonka A, Rupprecht HJ, Prellwitz W, Meyer J, Erbel R. Guidance of anticoagulation after intracoronary implatation of Palmaz-Schatz stents bu monitoring prothrombin and prothrombin fragment 1+2. Am Heart J. 1995;130:228-238.
21. Splawinska B, Kuzniar J, Malinga K, Mazurek AP, Splawinski J. The efficacy and potency of antiplatelet activity of ticlopidine is increased by aspirin. Int J Clin Phrmacol Ther. 1996;34:352-356.
22. Gregorini L, Marco J, Fajadet J, Bernies M, Cassagneau B, Brunel P, Bossi IM, Mannucci PM. Ticlopidine and aspirin pretreatment reduces coagulation and platelet activation during coronary dilation procedures. J Am Coll Cardiol. 1997;29:13-20.
23. Leon MB, Baim DS, Gordon P, Giambartomei A. Williams DO, Diver DJ, Senerchia C, Fitzpatrick M, Popma JJ, Kuntz RE. Clinical and angiographic results from the stent anticoagulation regimen study (STARS). Circulation. 1996;94(suppl I):I-685.
24. Bertrand M, Legrand V, Boland J, Fleck E, Bonnier J, Emmanuelson H, Vrolix M, Missault L, Chierchia S, Casaccia m, Niccoli L. Full anticoagulation versus ticlopidine plus aspirin after stent implatation: a randomized multicenter European study: the FANTASTIC trial. Circulation. 1996;94(suppl I):I-685.
25. Gawaz M, Neumann FJ, Ott J, May A, Schömig A. Platelet activation and coronary stent implation: effect of antithrombotic therapy. Circulation. 1996;94:279-285.
26. Neumann FJ, Gawaz M, Ott I, May A, Mössmer G, Schörnig A. Prospective evaluation of hemostatíc predictors of subacute stent thrombosis after coronary Palmaz-Schatz stemtomg. J Am Coll Cardiol. 1996;27:15-21.
27. Hall P, Nakamura S, Maiello L, Itoh A, Blengino S, Martini G, Ferraro M, Colombo A. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation. 1996;93:215-222.
28. Rocca B, FitzGerald GA. Simply read: erythrocytes modulate platelet function: should we rethink the way we give aspirin? Circulation. 1997;95:11-13. Editorial and Comment.
29. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339.